- ￥1868
- abinScience
- France
- VK020042
- 2025年08月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
- 保质期：
1 year
- 英文名：
Recombinant Sapporo virus 3CL Protein, N-His
- 库存：
999
- 供应商：
abinScience
- 规格：
100ug
| Product name | Recombinant Sapporo virus 3CL Protein, N-His |
|---|---|
| Catalog No. | VK020042 |
| Form | Lyophilized |
| Storage buffer | Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| Purity | >90% |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | E. coli |
| Accession | Q672I1, Q69014 |
| Reconstitution | Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details. |
| Alternative Names | / |
| Species | Sapporo virus |
| Shipping | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003...
Product categories and application fields.
Main products...
Application field: Infectious disease research, Neuroscience, Immunology, Oncology
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• An Overview of the Crystallized Structures of the SARS-CoV-2., PMID:33098476
• Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19., PMID:34663813
• Molecular Generative Model via Retrosynthetically Prepared Chemical Building Block Assembly., PMID:36596675
• Characterization and inhibition of SARS-coronavirus main protease., PMID:16611148
• Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme., PMID:34097590
• Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS-CoV-2 using computational and in vitro approaches., PMID:35194277
• Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris., PMID:22350287
• In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2., PMID:34829954
• Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme., PMID:32837113
Scale-Up of recombinant virus and protein production in Stirred-Tank reactors
Stirred-tank fermentors were originally designed to perform microbial cultures (1 ). When the need arose for adequate, posttranslationally modified proteins, molecular biologists and bioprocess engineers turned to mammalian and insect cell
Preparation of Recombinant HIV-1 Gag Protein and Assembly of Virus-Like Particles In Vitro
. Here we describe a rapid method for the purification of Gag and its subsequent assembly into virus-like particles in a defined system in vitro. The purification scheme does not use affinity tags, but purifies the native protein by virtue of its high affinity
Functional Analysis of the N-Linked Glycans Within the Fusion Protein of Respiratory Syncytial Virus
The respiratory syncytial virus fusion (F) protein is initially expressed as a single polypeptide chain (F0). The F0 subsequently undergoes posttranslational cleavage-by-cell protease activity to produce the F1 and F2 subunits
技术资料暂无技术资料 索取技术资料
